Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 23;45(1):19.
doi: 10.1186/s41232-025-00384-3.

Ca2+ microdomain-based excitation-transcription coupling in cardiac myocytes and vascular smooth muscle cells

Affiliations
Review

Ca2+ microdomain-based excitation-transcription coupling in cardiac myocytes and vascular smooth muscle cells

Tsukasa Koide et al. Inflamm Regen. .

Abstract

Ca2+ signals play a crucial role in maintaining cardiovascular homeostasis, including regulation of the heartbeat, blood pressure, and adaptation to changes in the external environment. Conversely, abnormal Ca2+ signaling is often involved in the onset and progression of cardiovascular diseases, such as cardiac hypertrophy, heart failure, arteriosclerosis, and hypertension. In excitable cells, such as cardiac myocytes and vascular smooth muscle cells (VSMCs), membrane depolarization, and the subsequent elevation of cytosolic Ca2+ concentration ([Ca2+]cyt) via voltage-dependent Ca2+ channels (VDCCs) cause muscle contraction, which is known as excitation-contraction coupling (E-C coupling). Elevated [Ca2+]cyt can also activate Ca2+-dependent enzymes, in some cases leading to changes in gene expression patterns and contributing to long-term cellular responses. This mechanism is referred to as excitation-transcription coupling (E-T coupling), and it is involved in both the adaptive and pathological responses of the cardiovascular system to chronic stimulation. Specific intracellular regions, known as Ca2+ microdomains, exhibit localized increases in [Ca2+]cyt. Such localized Ca2+ signaling is now known to be one of the molecular mechanisms controlling the diversity of Ca2+ responses. These Ca2+ microdomains are often formed by complexes consisting of Ca2+ channels and downstream Ca2+-dependent enzymes localized by scaffolding proteins. This review outlines some of the molecular mechanisms and roles of Ca2+ microdomain-based E-T coupling in cardiac myocytes and VSMCs. First, we discuss the major molecular components that are essential for functional Ca2+ microdomains. For example, VDCC (CaV1.2 channel), ryanodine receptor (RyR), Ca2+-dependent enzymes (Ca2+/CaM-dependent kinase [CaMK], calcineurin [CaN], and calpain), and scaffolding proteins (A-kinase anchoring proteins [AKAPs], caveolin, and junctophilin). Next, we discuss the roles of Ca2+ microdomain-based E-T coupling in physiological and pathophysiological remodeling in cardiac myocytes and vascular smooth muscle cells.

Keywords: Ca2+ microdomain; Ca2+ signaling; Cardiac myocyte; Excitation-transcription coupling; Vascular smooth muscle cell.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
E-T Coupling in Cardiac myocytes. A AKAP5 localized in the T-tubules of cardiac myocytes cooperates with Cav3 to form complexes with CaV1.2 channels, β-AR, AC, PKA, and CaN, leading to activation of the CaN/NFAT pathway and contributing to cardiac hypertrophy. Activation of CaMKIIδB via dephosphorylation by CaN activates CREB, inducing MCU expression and exerting cardioprotective effects. B Junctophilin 2 (Jph2) which tethers the T-tubules and SR is cleaved by calpain activated by sustained [Ca2+]cyt elevation. Jph2-NT, generated by calpain-1, has a cardioprotective effect. In contrast, Jph2-CT, generated by calpain-2, is involved in cardiac hypertrophy. C Pressure overload and/or maintained neurohormonal stimulation increase both [Ca2+]cyt and [Ca2+]nuc. Calpain translocates CaN to the nucleus, and activates NFAT. This results in an increase in IP3R expression levels, and further enhances [Ca2+]nuc elevation. D Under chronic stimulation, CaMKIIδC accumulates in the perinuclear region and the nucleus, which promotes nuclear export of HDAC4, and thus activates MEF2. This can contribute to pathological remodeling. Furthermore, mAKAP on the nuclear membrane forms complexes with PKA, AC, and CaN, enhancing perinuclear Ca2+ signaling via RyR phosphorylation and activating the CaN/NFAT and CaN/MEF2 pathways, resulting in cardiac remodeling. AC: adenylyl cyclase, CaN: calcineurin, Cav3: caveolin 3, HDAC4: histone deacetylase 4, Jph2: junctophilin 2, Jph2-CT: C-terminal fragment of junctophilin 2, Jph2-NT: N-terminal fragment of junctophilin 2, mAKAP: muscle-specific A-kinase anchoring protein, MCU: mitochondrial Ca2+ uniporter, RyR: ryanodine receptor, SR: sarcoplasmic, β-AR: β-adrenergic receptor
Fig. 2
Fig. 2
E-T coupling in vascular smooth muscle cells. A Phosphorylation of CaV1.2 channel by AT1R/PKC or P2Y11/PKA increases CaV1.2 channel clustering as well as co-operative interactions of these channels. NFAT translocates to the nucleus via dephosphorylation by CaN anchored to AKAP5. Agonist stimulation or pressure loading suppresses JNK2, stabilizing NFAT nuclear localization. Nuclear NFAT downregulates the expression of both BKCa subunits and Kv2.1, enhancing membrane depolarization. B Ca2+ influx mediated by CaV1.2 channels clustered in caveolae activates CaMKK2/CaMKI in a spatially localized fashion. CaMKI, phosphorylated by CaMKK2, translocates to the nucleus and activates CREB, where it may induce genes that produce pro-inflammatory products (e.g., cytokines and chemokines). AT1R: Angiotensin II type 1 receptor, BKCa: Large conductance Ca2+-activated K+ channel, CaN: calcineurin, Cav1: caveolin 1, JNK2: c-Jun N-terminal kinase 2, P2Y11: P2Y purinoreceptor 11, PM: plasma membrane

Similar articles

References

    1. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4:517–29. 10.1038/NRM1155. - PubMed
    1. Dewenter M, Von Der Lieth A, Katus HA, Backs J. Calcium signaling and transcriptional regulation in cardiomyocytes. Circ Res. 2017;121:1000–20. 10.1161/CIRCRESAHA.117.310355. - PubMed
    1. Touyz RM, Alves-Lopes R, Rios FJ, Camargo LL, Anagnostopoulou A, Arner A, et al. Vascular smooth muscle contraction in hypertension. Cardiovasc Res. 2018;114:529–39. 10.1093/CVR/CVY023. - PMC - PubMed
    1. Inoue R, Jensen LJ, Shi J, Morita H, Nishida M, Honda A, et al. Transient receptor potential channels in cardiovascular function and disease. Circ Res. 2006;99:119–31. 10.1161/01.RES.0000233356.10630.8A. - PubMed
    1. Gilbert G, Demydenko K, Dries E, Puertas RD, Jin X, Sipido K, et al. Calcium signaling in cardiomyocyte function. Cold Spring Harb Perspect Biol. 2020;12:a035428. 10.1101/CSHPERSPECT.A035428. - PMC - PubMed

LinkOut - more resources